275 related articles for article (PubMed ID: 37143472)
1. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps.
Zuo Y; Leng G; Leng P
Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472
[No Abstract] [Full Text] [Related]
2. Machine learning framework develops neutrophil extracellular traps model for clinical outcome and immunotherapy response in lung adenocarcinoma.
Han AX; Long BY; Li CY; Huang DD; Xiong EQ; Li FJ; Wu GL; Liu Q; Yang GB; Hu HY
Apoptosis; 2024 Mar; ():. PubMed ID: 38519636
[TBL] [Abstract][Full Text] [Related]
3. A Six-gene Prognostic Model Based on Neutrophil Extracellular Traps (NETs)-related Gene Signature for Lung Adenocarcinoma.
Mo G; Long X; Cao L; Tang Y; Yan Y; Guo T
Comb Chem High Throughput Screen; 2024 Feb; ():. PubMed ID: 38357943
[TBL] [Abstract][Full Text] [Related]
4. A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma.
Ding W; Li B; Zhang Y; He L; Su J
Front Genet; 2022; 13():1047231. PubMed ID: 36419832
[No Abstract] [Full Text] [Related]
5. Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma.
Zhang W
Medicine (Baltimore); 2023 Nov; 102(46):e35526. PubMed ID: 37986388
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps.
Quan J; Huang B
Front Cell Dev Biol; 2022; 10():1021690. PubMed ID: 36523511
[No Abstract] [Full Text] [Related]
7. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
8. A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma.
Wang H; Shi Y; Xu X; Xu S; Shi Y; Chen W; Wang K
Ann Med; 2023; 55(2):2279754. PubMed ID: 37980632
[TBL] [Abstract][Full Text] [Related]
9. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
Zeng C; Yu H; Liu X; Liu Q; Jin J
Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme.
Sun G; Liu W
Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685
[TBL] [Abstract][Full Text] [Related]
12. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
Wang J; Shu J
Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
[TBL] [Abstract][Full Text] [Related]
13. Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.
Cao K; Liu M; Ma K; Jiang X; Ma J; Zhu J
Cancer Immunol Immunother; 2022 Jun; 71(6):1295-1311. PubMed ID: 34652523
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
Shu J; Jiang J; Zhao G
Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
16. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
17. Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps.
Zheng Y; Sun H; Yang S; Liu W; Jiang G
J Cancer; 2024; 15(9):2678-2690. PubMed ID: 38577608
[No Abstract] [Full Text] [Related]
18. Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps.
Tu Y; Mao Z
Cancer Invest; 2023 Apr; 41(4):354-368. PubMed ID: 36762827
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.
Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L
Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758
[TBL] [Abstract][Full Text] [Related]
20. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
